Results 211 to 220 of about 92,853 (340)

Late Gadolinium Enhancement and Electrocardiographic Associations in Hypertrophic Cardiomyopathy

Annals of Noninvasive Electrocardiology, Volume 30, Issue 4, July 2025.
Late gadolinium enhancement (LGE) is a negative prognostic marker in hypertrophic cardiomyopathy (HCM). In pediatric patients with HCM, greater LGE presence is associated with a paradoxical reduction in left ventricular precordial lead voltages on the electrocardiogram.
Issa Asfour, Shahid Karim, Sair A. Tabraiz, Anwar Chahal, Mohammed Y. Khanji, Akil A. Sherif, Steve R. Ommen, Virend K. Somers, Grace Lin, Peter A. Brady   +9 more
wiley   +1 more source

Improved micro-radioimmunoassay of digoxin in serum, with use of 125I-labeled digoxin. [PDF]

, 1976
B Calesnick, A. Dinan
openalex   +1 more source

Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in Japan

Diabetes, Obesity and Metabolism, Volume 27, Issue 7, Page 3714-3724, July 2025.
Abstract Aims To describe temporal changes in the characteristics of medication‐initiator cohorts in persons with chronic kidney disease (CKD) and type 2 diabetes (T2D). Materials and Methods Adults with CKD and T2D initiating sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) or glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) were identified in ...
Yuichiro Yano, Suguru Okami, Hiroshi Kanegae, Nikolaus G. Oberprieler, Catherine Johannes, Satoshi Yamashita, Kanae Yoshikawa‐Ryan, Csaba P. Kovesdy, David Vizcaya, Naoki Kashihara   +9 more
wiley   +1 more source

Balancing Act: Digoxin Antidote Supply and Demand in New South Wales, Australia. [PDF]

Emerg Med Australas
Jeong J, Buckley NA, Cairns R, Chan BS.
europepmc   +1 more source

Modification of a Commercially Available Digoxin Radioimmunoassay Kit for Higher Precision [PDF]

, 1975
W. J. F. van der Vijgh
openalex   +1 more source

Digoxin toxicity due to interaction of digoxin with erythromycin. [PDF]

BMJ, 1989
M. R. Hall, S. K. Gilmour-White, D. L. Maxwell   +2 more
openaire   +3 more sources

Mortality risk following ischaemic and non‐ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000–2021

Diabetes, Obesity and Metabolism, Volume 27, Issue 7, Page 3848-3857, July 2025.
Abstract Aims To investigate the association between type 2 diabetes and all‐cause mortality in people with ischaemic and non‐ischaemic heart failure (HF). Methods Using the Clinical Practice Research Datalink primary care data, linked to hospital and mortality records, we identified newly diagnosed adults with type 2 diabetes between 2000 and 2021 and
Kajal Panchal, Claire A. Lawson, Sharmin Shabnam, Kamlesh Khunti, Francesco Zaccardi   +4 more
wiley   +1 more source

Role of Digoxin in Preventing Cigarette Smoke-Induced COPD via HIF-1α Inhibition in a Mouse Model. [PDF]

Int J Chron Obstruct Pulmon Dis
Zhang K, Zhou F, Zhu C, Yuan L, Li D, Wang J, Lu W.   +6 more
europepmc   +1 more source

Measuring digoxin. [PDF]

, 1970

openalex   +1 more source

Digoxin promotes anoikis of circulating cancer cells by targeting Na⁺/K⁺-ATPase α3-isoform. [PDF]

Cell Death Dis
Numata Y, Fujii T, Toda C, Okumura T, Manabe T, Takeda N, Shimizu T, Tabuchi Y, Fujii T, Sakai H.   +9 more
europepmc   +1 more source